Allie Nawrat

You can get in touch with Allie on Alexandra.Nawrat@verdict.co.uk

All articles by Allie Nawrat

  1. FDA approves first generic of Mylan’s EpiPen

    The US Food and Drug Administration (FDA) has approved the first generic version of the EpiPen and EpiPen Jr (epinephrine)…
    Read More…

    17 Aug
  2. Realm Therapeutics unveils phase II failure of PR022 for severe eczema

    US-based Realm Therapeutics has announced its drug candidate PR022 for atopic dermatitis has failed to achieve its primary endpoint in…
    Read More…

    16 Aug
  3. Janssen and ViiV report positive results for two drug regimen for HIV-1

    Johnson & Johnson subsidiary Janseen Pharmaceuticals and ViiV Healthcare have reported positive topline results from their phase III trial of…
    Read More…

    16 Aug
  4. NICE does not recommend NHS use of Biogen’s nusinersen for SMA

    The UK’s National Institute for Health and Care Excellence (NICE) has not recommended Biogen’s Spinraza (nusinersen) for routine use by…
    Read More…

    15 Aug
  5. Study shows remifentanil better at relieving pain in labour than current standard care

    An alternative opioid pain relief drug, remifentanil, can better relieve pain and reduces the need for an epidural for pregnant…
    Read More…

    15 Aug
  6. PhRMA survey shows US biopharma exceeded R&D spending record in 2017

    Spending by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) on research and development (R&D) set a new…
    Read More…

    14 Aug
  7. FDA approves first direct-to-consumer contraceptive app Natural Cycles

    The US Food and Drug Administration (FDA) has approved Sweden-based Natural Cycles, making it the first direct-to-consumer smartphone app used…
    Read More…

    14 Aug
  8. The road to market: breaking down the stages of clinical trials for pharmaceutical products

    According to the World Health Organisation (WHO) a clinical trial is defined as ‘any research study that prospectively assigns human…
    Read More…

    14 Aug
  9. Researchers uncover pathogenic mechanism causing IPF

    A research team from Helmholz Zentrum München’s Department of Lung Repair and Regeneration (LRR) with support from the University of…
    Read More…

    13 Aug
  10. NICE suspends review of Vertex’s Symkevi for cystic fibrosis

    The UK’s National Institute for Health and Care Excellence (NICE) has suspended its review of Vertex Pharmaceuticals’ cystic fibrosis (CF)…
    Read More…

    13 Aug